Vaccine Safety and Efficacy Evaluation of a Recombinant Bovine Respiratory Syncytial Virus (BRSV) with Deletion of the SH Gene and Subunit Vaccines Based On Recombinant Human RSV Proteins: N-nanorings, P and M2-1, in Calves with Maternal Antibodies

MLA

Blodorn, Krister, et al. “Vaccine Safety and Efficacy Evaluation of a Recombinant Bovine Respiratory Syncytial Virus (BRSV) with Deletion of the SH Gene and Subunit Vaccines Based On Recombinant Human RSV Proteins: N-Nanorings, P and M2-1, in Calves with Maternal Antibodies.” PLoS ONE, vol. 9, no. 6, June 2014. EBSCOhost, https://doi.org/10.1371/journal.pone.0100392⟩.

APA

Blodorn, K., Hagglund, S., Fix, J., Dubuquoy, C., Makabi-Panzu, B., Thom, M., Karlsson, P., Roque, J.-L., Karlstam, E., Pringle, J., Eleouet, J. F., Riffault, S., Taylor, G., & Valarcher, J. F. (2014). Vaccine Safety and Efficacy Evaluation of a Recombinant Bovine Respiratory Syncytial Virus (BRSV) with Deletion of the SH Gene and Subunit Vaccines Based On Recombinant Human RSV Proteins: N-nanorings, P and M2-1, in Calves with Maternal Antibodies. PLoS ONE, 9(6). https://doi.org/10.1371/journal.pone.0100392⟩

Chicago

Blodorn, Krister, Sara Hagglund, Jenna Fix, Catherine Dubuquoy, Boby Makabi-Panzu, Michelle Thom, Per Karlsson, et al. 2014. “Vaccine Safety and Efficacy Evaluation of a Recombinant Bovine Respiratory Syncytial Virus (BRSV) with Deletion of the SH Gene and Subunit Vaccines Based On Recombinant Human RSV Proteins: N-Nanorings, P and M2-1, in Calves with Maternal Antibodies.” PLoS ONE 9 (6). doi:10.1371/journal.pone.0100392⟩.